[Federal Register Volume 83, Number 32 (Thursday, February 15, 2018)]
[Proposed Rules]
[Pages 6822-6823]
[FR Doc No: 2018-03079]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 52

[EPA-R04-OAR-2017-0557; FRL-9974-46-Region 4]

Air Plan Approval; SC; VOC Definition

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: On September 5, 2017, the State of South Carolina, through the
South Carolina Department of Health and Environmental Control (SC
DEHC), submitted changes to the South Carolina State Implementation
Plan (SIP). Specifically, the revision pertains to the modification of
the definition of ``volatile organic compounds'' (VOCs). EPA is
proposing to approve the SIP revision because the State has
demonstrated that these changes are consistent with the Clean Air Act
(CAA or Act).

DATES: Written comments must be received on or before March 19, 2018.

ADDRESSES: Submit your comments, identified by Docket ID No. EPA-R04-
OAR-2017-0557 at http://www.regulations.gov. Follow the online
instructions for submitting comments. Once submitted, comments cannot
be edited or removed from Regulations.gov. EPA may publish any comment
received to its public docket. Do not submit electronically any
information you consider to be Confidential Business Information (CBI)
or other information whose disclosure is restricted by statute.
Multimedia submissions (audio, video, etc.) must be accompanied by a
written comment. The written comment is considered the official comment
and should include discussion of all points you wish to make. EPA will
generally not consider comments or comment contents located outside of
the primary submission (i.e., on the web, cloud, or other file sharing
system). For additional submission methods, the full EPA public comment
policy, information about CBI or multimedia submissions, and general
guidance on making effective comments, please visit http://www2.epa.gov/dockets/commenting-epa-dockets.

FOR FURTHER INFORMATION CONTACT: Richard Wong, Air Regulatory
Management Section, Air Planning and Implementation Branch, Air,
Pesticides and Toxics Management Division, U.S. Environmental
Protection Agency, Region 4, 61 Forsyth Street SW, Atlanta, Georgia
30303-8960. The telephone number is<PHONE_NUMBER>. Mr. Wong can be
reached via electronic mail at [email protected].

SUPPLEMENTARY INFORMATION:

I. Background

    In this rulemaking, EPA is proposing to approve changes to the
South Carolina SIP, submitted by the State on September 5, 2017. The
submission revises Regulation 61-62.1--Definitions and General
Requirements, by removing the recordkeeping, emissions reporting,
photochemical dispersion modeling, and inventory requirements for t-
Butyl acetate.
    Tropospheric ozone, commonly known as smog, occurs when VOCs and
nitrogen oxides (NOX) react with sunlight in the atmosphere.
Because of the harmful health effects of ozone, EPA limits the amount
of VOCs and NOX that can be released into the atmosphere.
VOCs are those compounds of carbon (excluding carbon monoxide, carbon
dioxide, carbonic acid, metallic carbides or carbonates, and ammonium
carbonate) that participate in atmospheric photochemical reactions.
Different VOCs have different levels of reactivity; they do not react
at the same speed or form ozone to the same extent.
    EPA determines whether a given carbon compound has ``negligible''
reactivity by comparing the compound's reactivity to the reactivity of
ethane. It has been EPA's policy that compounds of carbon with
negligible reactivity need not be regulated to reduce ozone. See 42 FR
35314, July 8, 1977. EPA lists these compounds in its regulations at 40
CFR 51.100(s) and excludes them from the definition of VOC. The
chemicals on this list are often called ``negligibly reactive.'' EPA
may periodically revise the list of negligibly reactive compounds to
add or delete compounds.
    On November 29, 2004 (69 FR 69298), EPA issued a final rule
revising the definition of VOCs at 40 CFR 51.100(s) by adding tertiary
butyl acetate (or t-Butyl acetate or TBAC) to the list of compounds
that are considered to be negligibly reactive and excluded from the
definition of VOCs. Additionally, on February 25, 2016 (81 FR 9339),
EPA issued a final rule further revising the definition of VOC at 40
CFR 51.100(s) by removing the recordkeeping, emissions reporting,
photochemical dispersion modeling, and inventory requirements for t-
Butyl acetate. EPA removed these requirements in part because there was
no evidence that TBAC was being used at levels that cause concern for
ozone formation and because the data that had been collected under
these requirements had proven to be of limited utility in judging the
cumulative impacts of exempted compounds.\1\ 81 FR 9339, 9341.
---------------------------------------------------------------------------

    \1\ In the 2016 EPA rule, EPA also discussed the efforts
surrounding any future determinations about the health risks
associated with TBAC, including noting that data collected through
the recordkeeping and reporting requirements did not appear relevant
to any such future determinations and that EPA was assessing the
health risks from TBAC through its Integrated Risk Information
System. This effort is on-going and more information regarding
health risks may be found at EPA's previous 2016 rulemaking (81 FR
9339, 9341).
---------------------------------------------------------------------------

II. EPA's Analysis of South Carolina's SIP Revision

    The State's September 5, 2017, SIP revision removes the
recordkeeping, emissions reporting, photochemical dispersion modeling,
and inventory requirements for t-Butyl acetate.\2\ The revision removes
Regulation 61-62.1 paragraph 100(c). EPA is proposing to approve the
revision because it is consistent with the definition of VOC at 40 CFR
51.100(s) and satisfies CAA section 110(l) requirements.
---------------------------------------------------------------------------

    \2\ EPA previously approved a SIP revision from South Carolina
which revised its definition of VOC to add t-Butyl acetate to the
list of negligibly reactive compounds (72 FR 30704).
---------------------------------------------------------------------------

    Pursuant to CAA section 110(l), the Administrator shall not approve
a revision of a plan if the revision would interfere with any
applicable requirement concerning attainment and reasonable further
progress, or any other applicable requirement of the Act. EPA proposes
to find that the State's removal of the recordkeeping, emissions
reporting, photochemical dispersion modeling, and inventory
requirements for t-Butyl acetate is approvable under section 110(l)
because it reflects changes to Federal regulations based on findings

that TBAC is negligibly reactive, that there was no evidence that TBAC
was being used at levels that cause concern for ozone formation, and
that the data that had been collected under these reporting,
recordkeeping, modeling, and inventory requirements had proven to be of
limited utility in judging the cumulative impacts of exempted
compounds, like TBAC.\3\
---------------------------------------------------------------------------

    \3\ This current proposed rulemaking does not, and is not
intended to, reopen any prior final EPA rulemaking or findings made
therein, including EPA's 2004 final rule (69 FR 69298) and EPA's
2016 final rule (81 FR 9339).
---------------------------------------------------------------------------

III. Incorporation by Reference

    In this rule, EPA is proposing to include in a final EPA rule
regulatory text that includes incorporation by reference. In accordance
with requirements of 1 CFR 51.5, EPA is proposing to incorporate by
reference Regulation 61-62.1--Definitions and General Requirements,
effective August 25, 2017. EPA has made, and will continue to make,
these materials generally available through www.regulations.gov and at
the EPA Region 4 office (please contact the person identified in the
FOR FURTHER INFORMATION CONTACT section of this preamble for more
information).

IV. Proposed Action

    EPA is proposing to approve South Carolina's September 5, 2017,
submission submitted by the State of South Carolina through SC DEHC.
The submission revises Regulation 61-62.1--Definitions and General
Requirements.

V. Statutory and Executive Order Reviews

    Under the CAA, the Administrator is required to approve a SIP
submission that complies with the provisions of the Act and applicable
Federal regulations. See 42 U.S.C. 7410(k); 40 CFR 52.02(a). Thus, in
reviewing SIP submissions, EPA's role is to approve state choices,
provided that they meet the criteria of the CAA. This action merely
proposes to approve state law as meeting Federal requirements and does
not impose additional requirements beyond those imposed by state law.
For that reason, this proposed action:
     Is not a significant regulatory action subject to review
by the Office of Management and Budget under Executive Orders 12866 (58
FR 51735, October 4, 1993) and 13563 (76 FR 3821, January 21, 2011);
     Is not an Executive Order 13771 (82 FR 9339, February 2,
2017) regulatory action because SIP approvals are exempted under
Executive Order 12866.
     Does not impose an information collection burden under the
provisions of the Paperwork Reduction Act (44 U.S.C. 3501 et seq.);
     Is certified as not having a significant economic impact
on a substantial number of small entities under the Regulatory
Flexibility Act (5 U.S.C. 601 et seq.);
     Does not contain any unfunded mandate or significantly or
uniquely affect small governments, as described in the Unfunded
Mandates Reform Act of 1995 (Pub. L. 104-4);
     Does not have Federalism implications as specified in
Executive Order 13132 (64 FR 43255, August 10, 1999);
     Is not an economically significant regulatory action based
on health or safety risks subject to Executive Order 13045 (62 FR
19885, April 23, 1997);
     Is not a significant regulatory action subject to
Executive Order 13211 (66 FR 28355, May 22, 2001);
     Is not subject to requirements of Section 12(d) of the
National Technology Transfer and Advancement Act of 1995 (15 U.S.C. 272
note) because application of those requirements would be inconsistent
with the CAA; and
     Does not provide EPA with the discretionary authority to
address, as appropriate, disproportionate human health or environmental
effects, using practicable and legally permissible methods, under
Executive Order 12898 (59 FR 7629, February 16, 1994).
    In addition, this proposed rule for South Carolina does not have
Tribal implications as specified by Executive Order 13175 (65 FR 67249,
November 9, 2000), because it does not have substantial direct effects
on an Indian Tribe. The Catawba Indian Nation Reservation is located
within the state of South Carolina. Pursuant to the Catawba Indian
Claims Settlement Act, S.C. Code Ann. 27-16-120, ``all state and local
environmental laws and regulations apply to the [Catawba Indian Nation]
and Reservation and are fully enforceable by all relevant state and
local agencies and authorities.'' EPA notes this action will not impose
substantial direct costs on Tribal governments or preempt Tribal law.

List of Subjects in 40 CFR Part 52

    Environmental protection, Air pollution control, Incorporation by
reference, Intergovernmental relations, Nitrogen dioxide, Ozone,
Particulate matter, Reporting and recordkeeping requirements, Volatile
organic compounds.

    Authority: 42 U.S.C. 7401 et seq.

    Dated: February 6, 2018.
Onis ``Trey'' Glenn, III,
Regional Administrator, Region 4.
[FR Doc. 2018-03079 Filed 2-14-18; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 82, Number 178 (Friday, September 15, 2017)]
[Notices]
[Pages 43354-43356]
[FR Doc No: 2017-19703]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OW-2016-0438; FRL-9967-69-OW]

Request for Public Comments To Be Sent to EPA on Peer Review
Materials To Inform the Safe Drinking Water Act Decision Making on
Perchlorate

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of request for public comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Environmental Protection Agency (EPA) is announcing
the release of materials for public comment. These materials will
undergo expert peer review in support of EPA's Safe Drinking Water Act
decision making for perchlorate. This request is one of two Federal
Register notices being published concurrently, seeking public comment
on two separate sets of peer review materials. This notice requests
comments (to be sent to EPA) on a draft report entitled ``Draft Report:
Proposed Approaches to Inform the Derivation of a Maximum Contaminant
Level Goal for Perchlorate in Drinking Water'' (draft MCLG Approaches
Report). The companion notice requests comments (to be sent to EPA's
contractor, Versar, Inc.) on an interim list of peer reviewers and
draft charge questions.

DATES: Comments must be received by EPA on or before October 30, 2017.

ADDRESSES: Submit your comments, identified by Docket ID No. EPA-HQ-OW-
2016-0438 to the Federal eRulemaking Portal: http://www.regulations.gov. Follow the online instructions for submitting
comments. Once submitted, comments cannot be edited or withdrawn. The
EPA may publish any comment received to its public docket. Do not
submit electronically any information you consider to be Confidential
Business Information (CBI) or other information whose disclosure is
restricted by statute. Multimedia submissions (audio, video, etc.) must
be accompanied by a written comment. The written comment is considered
the official comment and should include discussion of all points you
wish to make. The EPA will generally not consider comments or comment
contents located outside of the primary submission (i.e., on the web,
cloud, or other file sharing system). For additional submission
methods, the full EPA public comment policy, information about CBI or
multimedia submissions, and general guidance on making effective
comments, please visit http://www2.epa.gov/dockets/commenting-epa-dockets.

FOR FURTHER INFORMATION CONTACT: For additional information concerning
the draft MCLG Approaches Report, please contact Samuel Hernandez at
U.S. EPA, Office of Ground Water and Drinking Water, Standards and Risk
Management Division, (Mail Code 4607M), 1200 Pennsylvania Avenue NW.,
Washington, DC 20460; telephone:<PHONE_NUMBER>; or email:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Information on EPA's Revised Biologically Based Dose-Response (BBDR)
Model

    As a part of the national primary drinking water regulation (NPDWR)
development process for perchlorate, in accordance with the
requirements of the Safe Drinking Water Act, in 2012, EPA requested
comment from EPA's Science Advisory Board (SAB) prior to proposing an
MCLG and a NPDWR for perchlorate. EPA sought guidance on how best to
consider and interpret life stage information, epidemiologic and
biomonitoring data, physiologically-based pharmacokinetic analyses and
the totality of perchlorate health related information to derive a
perchlorate MCLG.
    In 2013, the SAB recommended that, ``. . . EPA derive a perchlorate
MCLG that addresses sensitive life stages through physiologically-based
pharmacokinetic/pharmacodynamic (PBPK/PD) modeling based upon its mode
of action rather than the default MCLG approach using the reference
dose and specific chemical exposure parameters'' (Advice on Approaches
to Derive a Maximum Contaminant Level Goal for Perchlorate, EPA-SAB-13-
004).
    Based on the SAB's recommendations, EPA, with contributions from
Food and Drug Administration scientists, developed a biologically based
dose response (BBDR) (also known as a PBPK/PD) model, to predict the
effects of perchlorate on serum thyroid hormone concentrations in
pregnant and lactating women exposed to perchlorate in drinking water
and in infants exposed via ingestion of perchlorate in formula or
breast milk.
    On January 10 and 11, 2017, EPA's contractor (Versar, Inc.)
conducted an independent, scientific peer review of EPA's draft BBDR
model and draft model report. The purpose of the peer review was to
provide a documented, independent, and critical review of the draft
BBDR model and draft model report and to identify any necessary
improvements to the model prior to being finalized. On March 29, 2017,
EPA received the final peer review report entitled, ``External Peer
Review for EPA's Draft Biologically Based Dose-Response (BBDR) Model
and Draft BBDR Model Report for Perchlorate in Drinking Water,'' which
is available through the EPA docket at https://www.regulations.gov/docket?D=EPA-HQ-OW-2016-0439.
    In developing the draft MCLG Approaches Report, EPA revised the
BBDR model to address those peer review recommendations that had the
greatest influence on the scientific rigor of the model and modeling
results. Those changes are described in the draft MCLG Approaches
Report. EPA will consider other peer review recommendations and public
comments in future revisions to the BBDR model and report.

II. Information on EPA's Draft Approaches To Inform the Derivation of a
Perchlorate MCLG

    The SAB also recommended that EPA, ``utilize a mode of action (MOA)
framework for developing the MCLG that links the steps in the proposed
mechanism leading from perchlorate exposure through iodide uptake
inhibition to thyroid hormone changes and finally neurodevelopmental
impacts.''
    EPA used the modeled thyroid hormone levels to predict potential
adverse health effects based on published epidemiology data
demonstrating a relationship between changes in thyroid hormone levels
and neurodevelopmental effects. This approach involved a focused review
of the literature connecting altered thyroid hormone levels to
neurodevelopmental outcomes for women in early pregnancy. EPA focused
on studies that provided a quantitative description of the relationship
between free thyroxine and neurodevelopment in infants and children
(e.g., intelligence quotient, verbal and problem solving skills and
motor coordination).
    EPA will present an array of approaches to inform the derivation of
an MCLG for perchlorate for expert peer review. Using the revised BBDR
model output, EPA linked statistical relationships derived from five
studies to implement the MOA framework linking perchlorate exposure to
neurodevelopmental impacts. All five studies assess the relationship
between thyroid hormone levels in women in early pregnancy and various
neurodevelopmental effects on children at various ages. Two studies
assess the relationship on the IQ of children 5 to 10 years of age, two
other studies assess the relationship on Bayley Scales of Infant
Development of children 1 to 2 years of age, and a fifth study assesses
the relationship on reaction time of children 5 to 6 years of age. An
additional approach uses the revised BBDR model output to predict the
percent change in the population of hypothyroxinemic (or the low-end of
normal thyroid hormone levels) pregnant women due to perchlorate
exposure.

III. How To Obtain the Draft MCLG Approaches Report and Revised BBDR
Model

    EPA's draft report entitled ``Draft Report: Proposed Approaches to
Inform the Derivation of a Maximum Contaminant Level Goal for
Perchlorate in Drinking Water'' is available electronically and can be
accessed using EPA's public docket at https://www.regulations.gov/docket?D=EPA-HQ-OW-2016-0438. The revised BBDR model code files can be
accessed at https://hero.epa.gov/hero/index.cfm/reference/details/reference_id/3352518. All written comments must be submitted during the
public comment period.

IV. Exclusion for Peer Review Candidates

    Important: Anyone wishing to be considered as an expert peer
reviewer must not submit comments during the public comment period.
Candidates on the interim list not selected for the

panel peer review (see companion Peer Review Federal Register notice,
published on September 15, 2017) will be given a limited opportunity to
submit public comments once the final peer reviewers are selected by
Versar, Inc., the EPA contractor managing this peer review process.

    Dated: September 6, 2017.
Michael H. Shapiro,
Acting Assistant Administrator, Office of Water.
[FR Doc. 2017-19703 Filed 9-14-17; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register Volume 82, Number 162 (Wednesday, August 23, 2017)]
[Notices]
[Pages 40008-40009]
[FR Doc No: 2017-17855]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-D-1248]

Oncology Drugs for Companion Animals; Guidance for Industry;
Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
the availability of a guidance for industry #237 entitled ``Oncology
Drugs for Companion Animals.'' The guidance provides recommendations
for sponsors of investigational oncology drugs for use in companion
animals (e.g., dogs, cats, and horses), discusses the contents of a new
animal drug application for certain oncology drugs, and provides
recommendations on how to address human user safety concerns.

DATES: The announcement of the guidance is published in the Federal
Register on August 23, 2017.

ADDRESSES: You may submit either electronic or written comments on
Agency guidances at any time as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2016-D-1248 for ``Oncology Drugs for Companion Animals.'' Received
comments will be placed in the docket and, except for those submitted
as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff office between 9
a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
    Submit written requests for single copies of the guidance to the
Policy and Regulations Staff (HFV-6), Center for Veterinary Medicine,
Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855.
Send one self-addressed adhesive label to assist that office in
processing your requests. See the SUPPLEMENTARY INFORMATION section for
electronic access to the guidance document.

FOR FURTHER INFORMATION CONTACT: Christopher Loss, Center for
Veterinary Medicine (HFV-116), Food and Drug Administration, 7500
Standish Pl., Rm. N310, Rockville, MD 20855,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of June 10, 2016 (81 FR 37605), FDA
published the notice of availability for a draft guidance entitled
``Oncology Drugs for Companion Animals'' giving interested persons
until August 9, 2016, to comment on the draft guidance. FDA

received no comments on the draft guidance. The guidance announced in
this notice finalizes the draft guidance dated June 2015.

II. Significance of Guidance

    This level 1 guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The guidance represents
the current thinking of FDA on oncology drugs for companion animals. It
does not establish any rights for any person and is not binding on FDA
or the public. You can use an alternative approach if it satisfies the
requirements of the applicable statutes and regulations. This guidance
is not subject to Executive Order 12866.

III. Paperwork Reduction Act of 1995

    This guidance refers to previously approved collections of
information found in FDA regulations. These collections of information
are subject to review by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The
collections of information in 21 CFR 514.1 and 514.8 have been approved
under OMB control number 0910-0032.

IV. Electronic Access

    Persons with access to the internet may obtain the guidance at
either https://www.fda.gov/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/default.htm or
https://www.regulations.gov.

    Dated: August 18, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017-17855 Filed 8-22-17; 8:45 am]
BILLING CODE 4164-01-P


Reference Documents

Author(s)	Date

Modeling the Potential for Atrazine-Induced Changes in Midwestern Stream
Ecosystems using the Comprehensive Aquatic Systems Model (CASM). Final
Report. April 11, 2007.  MRID 47174103.	Disk 	Volz, D.C., S.M. Bartell,
S.K. Nair, and P. Hendley.	2007

Atrazine Ecological Exposure Flowing Water Chemical Monitoring Study in
Vulnerable Watersheds Interim Report: Watershed Selection Process.
Prepared by Waterborne Environmental, Inc., Leesburg, VA for Syngenta
Crop Protection, Inc., Greensboro, NC. March 30, 2004.  MRID 46249449
Disk 	Williams, W. M., Harbourt, C.M., Matella, M.K., Ball, M.H., and
Trask, J.R. 	2004a

2007 Interim Report - 2004 - 2006 Data Overview - Atrazine Ecological
Exposure Flowing Water Chemical Monitoring Study in Vulnerable
Watersheds Interim Report.  Prepared by Waterborne Environmental, Inc.,
Leesburg, VA for Syngenta Crop Protection, Inc., Greensboro, NC.  April
16, 2007. MRID 47174102.	Disk 	Hampton, M. Burnett, G., Carver, L.S.,
Harbourt, C.M., Hendley, P., Johnston, E.A., Perez, S., Snyder, N.J.,
and Trask, J.R. 	2007a

Atrazine Ecological Exposure Flowing Water Chemical Monitoring Study in
Vulnerable Watersheds: Analysis of Chemograph Behavior between Grab
Samples - Measurement and Hybrid PRZM Approaches.  Prepared by
Waterborne Environmental, Inc., Leesburg, VA for Syngenta Crop
Protection, Inc., Greensboro, NC.  August 8, 2007. MRID 47202000	Disk
Snyder, N.J., Harbourt, C.M., Miller, P.S., Trask, J.R., Prenger, J.J.,
Hendley, P., and Johnston, E.A.	2007

Atrazine Ecological Exposure Flowing Water Chemical Monitoring Study in
Vulnerable Watersheds: Approaches to Assessing Potential Watershed Scale
Vulnerability for Atrazine Runoff.  Prepared by Waterborne
Environmental, Inc., Leesburg, VA for Syngenta Crop Protection, Inc.,
Greensboro, NC. April 20, 2007. MRID 47174101.

	Disk 	Hampton, M. Prenger, J.J., Harbourt, C.M., Hendley, P., and
Miller, P.S.  	2007b

Atrazine Ecological Exposure Monitoring Program Interim Report:
Supporting Spatial Data.  Prepared by Waterborne Environmental, Inc.,
Leesburg, VA for Syngenta Crop Protection, Inc., Greensboro, NC.  March
30, 2004.  MRID 46249450	Disk 	Williams, W. M., Harbourt, C.M., Ball,
M.H., Matella, M.K., Trask, J.R., and Snyder, N.J. 	2004b


[Federal Register: July 27, 2009 (Volume 74, Number 142)]
[Notices]
[Page 37090]
[DOCID:fr27jy09-100]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

[Summary Notice No. PE-2007-30]

Petition for Exemption; Summary of Petition Received

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of petition for exemption received.

-----------------------------------------------------------------------

SUMMARY: This notice contains a summary of a petition seeking relief
from specified requirements of 14 CFR. The purpose of this notice is to
improve the public's awareness of, and participation in, this aspect of
FAA's regulatory activities. Neither publication of this notice nor the
inclusion or omission of information in the summary is intended to
affect the legal status of the petition or its final disposition.

DATES: Comments on this petition must identify the petition docket
number involved and must be received on or before August 17, 2009.

ADDRESSES: You may send comments identified by Docket Number FAA-2009-
0407 using any of the following methods:
     Government-wide rulemaking Web site: Go to http://
www.regulations.gov and follow the instructions for sending your
comments electronically.
     Mail: Send comments to the Docket Management Facility;
U.S. Department of Transportation, 1200 New Jersey Avenue, SE., West
Building Ground Floor, Room W12-140, Washington, DC 20590.
     Fax: Fax comments to the Docket Management Facility at
202-493-2251.
     Hand Delivery: Bring comments to the Docket Management
Facility in Room W12-140 of the West Building Ground Floor at 1200 New
Jersey Avenue, SE., Washington, DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
    Privacy: We will post all comments we receive, without change, to
http://www.regulations.gov, including any personal information you
provide. Using the search function of our docket Web site, anyone can
find and read the comments received into any of our dockets, including
the name of the individual sending the comment (or signing the comment
for an association, business, labor union, etc.). You may review DOT's
complete Privacy Act Statement in the Federal Register published on
April 11, 2000 (65 FR 19477-78).
    Docket: To read background documents or comments received, go to
http://www.regulations.gov at any time or to the Docket Management
Facility in Room W12-140 of the West Building Ground Floor at 1200 New
Jersey Avenue, SE., Washington, DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.

FOR FURTHER INFORMATION CONTACT: Ralen Gao, Office of Rulemaking, 800
Independence Ave., SW., Room 810, Washington, DC 20591.
    This notice is published pursuant to 14 CFR 11.85.

    Issued in Washington, DC, on July 21, 2009.
Pamela Hamilton-Powell,
Director, Office of Rulemaking.

Petition for Exemption

    Docket No.: FAA-2009-0407.
    Petitioner: Atlas Air and Polar Air Cargo.
    Section of 14 CFR Affected: 14 CFR 25.1301(a), Sec.  25.1415(b),
Sec.  91.9(a) and (b), Sec.  121.153(a)(2), Sec.  121.339(a)(2)
    Description of Relief Sought: Atlas Air seeks to replace its
pressure check visual inspection interval from before each takeoff to
an ``A'' check interval, conducted every 650 flight hours, or
approximately every 54 days.

[FR Doc. E9-17772 Filed 7-24-09; 8:45 am]

BILLING CODE 4910-13-P